Polyneuron Pharmaceuticals AG

📍 Basel, Switzerland🗓 Founded 2014👥 4 employees💰 Last funded Mar 2019
Pharmaceutical Manufacturing🌐 polyneuron.com
Website LinkedIn
Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-Catch™ technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs. We are a team of passionate and experienced scientists, entrepreneurs and investors willing to bring new therapies to patients.
3
Total investors
0
Early stage
3
Mid stage
0
Late stage
2014
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
France
1
United States
1
Switzerland
1
Investor activity2018–2019 · investors recorded per year
2018120192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Polyneuron Pharmaceuticals AG?
Polyneuron Pharmaceuticals AG has 3 investors on record on gritt.io, 3 mid-stage.
When did Polyneuron Pharmaceuticals AG last raise funding?
The most recent investment in Polyneuron Pharmaceuticals AG recorded on gritt.io was in March 2019.
When was Polyneuron Pharmaceuticals AG founded?
Polyneuron Pharmaceuticals AG was founded in 2014.
What industry is Polyneuron Pharmaceuticals AG in?
Polyneuron Pharmaceuticals AG operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Polyneuron Pharmaceuticals AG based?
Polyneuron Pharmaceuticals AG is headquartered in Basel, Switzerland.